Category: by country

High-profile Science paper retracted for misconduct

Science has retracted a high-profile immunology paper after a probe concluded the corresponding author had committed misconduct.

The paper — which initially caught media attention for suggesting a protein could help boost the immune system’s ability to fight off tumors — has been under a cloud of suspicion since last year, when the journal tagged it with an expression of concern, citing a university investigation.

That investigation — at Imperial College London — has concluded that the paper contained problematic figures that were the result of research misconduct. All were prepared by last and corresponding author Philip Ashton-Rickardt, who took full responsibility. Even though the paper was published in 2015, some original blots and accompanying details have disappeared.

Today, the journal released a retraction notice: Continue reading High-profile Science paper retracted for misconduct

Journal pulls cancer paper that used others’ data; authors MIA

A journal has retracted a paper after a reader pointed out some of the data looked familiar — and the authors never responded to the allegations.

According to the retraction notice in the International Journal of Molecular Medicine, the reader showed the journal that the histological data in two of the figures were from another published paper by different researchers. But when the journal contacted the authors on several occasions, they didn’t hear back. 

Here’s the retraction notice: Continue reading Journal pulls cancer paper that used others’ data; authors MIA

We’re not “citation police:” No more errata for omitted citations, says economics journal

An economics journal has corrected a paper for the second time for failing to cite previous studies — and said in a separate note that it no longer plans to publish similar errata, with rare exceptions. 

In September 2015, we reported on the first erratum for “Incentives for Creativity” — a paper that analyzed ways of inspiring creativity in the workplace — after it failed to cite relevant papers. One year on, the same paper has another erratum for a similar reason: not citing relevant papers from another field.

You don’t often see two errata for the same mistake — omitted citations — on one paper. Even less often do you see journal editors co-publishing a note saying they don’t plan on issuing any more such notices. Here’s an excerpt from the editor’s note in Experimental Economics: Continue reading We’re not “citation police:” No more errata for omitted citations, says economics journal

Spam me once, shame on you. (Academic) spam me 3000 times…?

Every year, academics get thousands of spam emails inviting them to submit manuscripts or attend conferences — but don’t bother asking to “unsubscribe” for Christmas.

Spoiler alert, for those of you planning to read the rest of this post: It doesn’t make much of a difference.

That’s according to the conclusions of a study published in one of our favorite issues of the BMJ  — the Christmas issue. After a group of five self-described “intrepid academics” tried to unsubscribe from the 300+ spam invitations they received on average each month, the volume decreased by only 19% after one year.

Not surprisingly, many emails — approximately 1 in 6 — were duplicates (aka “reheated spam”), and the vast majority (83%) had little relevance to the researchers’ interests.

Study author Andrew Grey at the University of Auckland told us that since it’s the BMJ Christmas issue, they wanted to have a bit of fun. But it’s not an all-together light topic, he noted: Continue reading Spam me once, shame on you. (Academic) spam me 3000 times…?

Judge tosses case, saying that court-ordered retractions are not part of scientific publication

“Retractions are part and parcel of academic and scientific publication. Court ordered retractions are not.”

So ends a judge’s September 30, 2016 opinion dismissing a case brought in 2014 by Andrew Mallon, a former Brown University postdoc, alleging that his advisor and former business partner, John Marshall, had published a paper in 2013 in PLOS Biology that should have listed him as a co-author.

As with most court cases, this one had a long backstory: An earlier version of the paper had listed Mallon as a co-author, but was rejected by Neuron in 2011; after the authors had a dispute over the data, a different version of the manuscript was submitted to PLOS Biology in 2012, leaving Mallon off the co-author list. So Mallon had sued to have the paper retracted.

In communications with Retraction Watch and other media, as well as during depositions of the plaintiffs, Mallon referred frequently to allegations of scientific misconduct, including the fact that the first author of the PLOS Biology paper had an unrelated paper retracted in 2010 for duplicated data. However, this case was brought under the Copyright Act, which focused on the authorship dispute.

Kevin Tottis, who represented Marshall and co-defendant Dennis Goebel, told Retraction Watch his clients “are delighted with the judge’s decision.” Massachusetts District Court Judge Timothy Hillman, he said, Continue reading Judge tosses case, saying that court-ordered retractions are not part of scientific publication

Prominent cancer researcher committed nearly 30 acts of misconduct

An investigation into the lab of a prominent cancer researcher in British Columbia has revealed nearly 30 acts of misconduct.   

As we detail in our latest feature for Science, the investigation, at the University of British Columbia (UBC), uncovered 29 instances of scientific misconduct, 16 of which were characterized as “serious,” according to university correspondence obtained by Retraction Watch.

The researcher, Sandra Dunn, is prominent in her field, but she left UBC in 2015 under unclear circumstances, shortly after it concluded its investigation. Dunn now heads a private company, Phoenix Molecular Designs, which says it develops therapies for cancer patients and lists local charities among its “partners and supporters.” While at UBC, Dunn obtained at least $1.1 million dollars in Canadian federal funding, some of which was used to support the falsified studies.

To some of the people involved, the most unsettling part of the incident is that it appears Dunn still receives support from Canadian charities. Continue reading Prominent cancer researcher committed nearly 30 acts of misconduct

A journal said it would retract a paper about asbestos — now it’s “withdrawn.” What changed?

journal-of-occupational-and-environmental-hygieneEarlier this year, an environmental journal told an activist group it was going to retract a study about the safety of roofing products made from asbestos. Now the journal has let the authors withdraw the paper — a different process, according to the journal.

The move follows multiple letters from critics asking to retract a study, which found exposure to asbestos-containing roofing products to be within safe limits. The study’s critics claimed that it contains multiple problems, including not declaring the approving editor’s links with the asbestos industry, grouping together different materials with varying levels of asbestos exposures, and providing misleading information.

Although the Journal of Occupational and Environmental Hygiene (JOEH) initially said it planned to retract the paper, last month, Stephen Reynolds, president of JOEH’s board of directors, sent a letter to Kathleen Ruff, director of the organization Right On Canada, saying plans had changed: Continue reading A journal said it would retract a paper about asbestos — now it’s “withdrawn.” What changed?

U.S. gov’t scientist says he was banned from climate research at work — so he used a pseudonym

A scientist working for the U.S. government says he was told not to work on climate research during working hours, nor reveal his government affiliation when presenting results. So he published his research under a pseudonym instead.

The researcher explains all this in a recent erratum for one of the papers he published under a different moniker — confirming why he and his co-author used the same pseudonyms to publish another now-withdrawn paper that presented some controversial climate findings. That withdrawal — which we covered in in September (as did the Washington Post) — raised eyebrows after Twitter users began pointing out that the authors — Den Volokin and Lark ReLlez — have similar names to another pair of researchers: Ned Nikolov and Karl Zeller. 

Nikolov’s use of a pseudonym even prompted a misconduct investigation by his employer, the U.S. Department of Agriculture Forest Service.

Here’s the erratum, issued last week for a 2014 paper in SpringerPlus:

Continue reading U.S. gov’t scientist says he was banned from climate research at work — so he used a pseudonym

UCLA lab pulls two papers — one by author who admitted to misconduct

A lab at the University of California, Los Angeles has retracted two papers for duplicated images.

These retractions — in the Journal of Immunology — represent the second and third retractions for the lab head; he lost another paper after one of his former students confessed to manipulating images.

Although Eriko Suzuki admitted to her actions on PubPeer in 2014, the 2007 Oncogene paper wasn’t retracted until June, 2016, when the journal issued a notice citing “data irregularities.”

Unfortunately, Suzuki’s admission in 2014 wasn’t the end of the troubles for lab head Benjamin Bonavida, who recently issued two additional retractions in the Journal of Immunology, only one of which includes Suzuki as a co-author.

Bonavida told us the university received allegations (he’s not sure from who) that some of the control gels were duplicated; he didn’t agree, but couldn’t produce the original gels to disprove it. We asked if any more retractions were coming from Bonavida, who has since retired from running a lab:

Continue reading UCLA lab pulls two papers — one by author who admitted to misconduct

Dear peer reviewer, you stole my paper: An author’s worst nightmare

“Deeply disturbing,” “heinous intellectual theft,” erosion of the “public’s trust in medical research:” These are just a few words used to describe a rare type of plagiarism reported in this week’s Annals of Internal Medicine.

Although we’ve only documented a few cases where peer reviewers steal material from manuscripts and pass them off as their own, it does happen, and it’s a fear of many authors. What we’ve never seen is a plagiarized author publish a letter to the reviewer who stole his work. But after Michael Dansinger of Tufts Medical Center realized a paper he’d submitted to Annals of Internal Medicine that had been rejected was republished, and the journal recognized one of the reviewers among the list of co-authors, it published a letter from Dansinger to the reviewer, along with an editorial explaining what happened.

The letter and editorial identify the paper containing the stolen material — now retracted — but don’t name the reviewer responsible. Still, the articles are deeply personal. As Dansinger writes in “Dear Plagiarist: A Letter to a Peer Reviewer Who Stole and Published Our Manuscript as His Own,” the reviewer took much more than just a manuscript:

Continue reading Dear peer reviewer, you stole my paper: An author’s worst nightmare